26 related articles for article (PubMed ID: 1764762)
1. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial.
Gao LL; Li YX; Ma JM; Guo YQ; Li L; Gao QH; Fan YN; Zhang MW; Tao XJ; Yu JQ; Yang JJ
Trials; 2021 Aug; 22(1):566. PubMed ID: 34521466
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Goff DC; D'Agostino RB; Haffner SM; Otvos JD
Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
[TBL] [Abstract][Full Text] [Related]
4. LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes.
Matsui J; Tamasawa N; Tanabe J; Kasai N; Murakami H; Yamato K; Guan J; Suda T
Diabetes Res Clin Pract; 2004 Dec; 66(3):229-36. PubMed ID: 15536019
[TBL] [Abstract][Full Text] [Related]
5. Abnormal particle size of lipoprotein in non-insulin-dependent diabetics and nondiabetics with and without hyperlipidemia.
Nakajo Y; Tanaka A; Uchimura I
Bull Tokyo Med Dent Univ; 1991 Dec; 38(4):63-71. PubMed ID: 1764762
[TBL] [Abstract][Full Text] [Related]
6. [Disorders of lipid metabolism in diabetes mellitus].
Biesenbach G
Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
8. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
9. Effects of various lipid-lowering treatments in diabetics.
Steiner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S35-9. PubMed ID: 1710744
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of lipoprotein analysis method by HPLC].
Yoshida H
Rinsho Byori; 2010 Nov; 58(11):1093-8. PubMed ID: 21229707
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
